| Christopher John Quibol, | |
|
3110 W Cheyenne Ave Ste 200a, N Las Vegas, NV 89032-2254 | |
| (702) 982-0600 | |
| Not Available |
| Full Name | Christopher John Quibol |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 3110 W Cheyenne Ave Ste 200a, N Las Vegas, Nevada |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275881252 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Christopher John Quibol, 3110 W Cheyenne Ave Ste 200a, N Las Vegas, NV 89032-2254 Ph: () - | Christopher John Quibol, 3110 W Cheyenne Ave Ste 200a, N Las Vegas, NV 89032-2254 Ph: (702) 982-0600 |
News Archive
A prototype drug created by researchers at the University of Illinois at Chicago shows promise in slowing replication of the virus responsible for severe acute respiratory syndrome, or SARS.
Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on the clinical development of epigenetic therapies in solid tumors, announced that previously reported results from ENCORE 401, a randomized, placebo controlled Phase 2 study of erlotinib with or without entinostat in advanced non-small cell lung cancer patients were published in the Journal of Clinical Oncology (JCO).
DJO Incorporated, a global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced financial results for its operating subsidiary, DJO Finance LLC ("DJOFL"), for the fourth quarter and fiscal year ended December 31, 2009. ReAble Therapeutics, Inc. ("ReAble") acquired DJO Incorporated ("DJO Opco") in a transaction completed on November 20, 2007 (the "DJO Merger").
National Institutes of Health scientists report that a single dose of an experimental Ebola virus (EBOV) vaccine completely protects cynomolgus macaques against the current EBOV outbreak strain, EBOV-Makona, when given at least seven days before exposure, and partially protects them if given three days prior.
› Verified 3 days ago
Mr. Daniel Warren Wheelock, M.ED. BA/FLE Counselor Medicare: Not Enrolled in Medicare Practice Location: 4513 Bell Cord Ave, N Las Vegas, NV 89031 Phone: 702-736-8100 | |
Miss Champain Angilique Coleman, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5124 Sierra Blanca Ln, N Las Vegas, NV 89031 Phone: 702-816-0044 | |
Thomas Mctyer, Counselor Medicare: Not Enrolled in Medicare Practice Location: 616 White Shark Ct, N Las Vegas, NV 89084 Phone: 702-834-0794 | |
Tiffany Langevin, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3755 W Lake Mead Blvd, N Las Vegas, NV 89032 Phone: 702-487-5665 | |
Shatana Shanice Harris-cobb, Counselor Medicare: Not Enrolled in Medicare Practice Location: 5332 Mountain Garland Ln, N Las Vegas, NV 89081 Phone: 661-466-8500 | |
Erin Nicole Higgs, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3110 W Cheyenne Ave, 200, N Las Vegas, NV 89032 Phone: 702-982-0600 | |
Adele Quibol, Counselor Medicare: Not Enrolled in Medicare Practice Location: 3110 W Cheyenne Ave Ste 200a, N Las Vegas, NV 89032 Phone: 702-982-0600 |